Decreased programmed cell death ligand 2-positive monocytic myeloid-derived suppressor cells and programmed cell death protein 1-positive T-regulatory cells in patients with type 2 diabetes: implications for immunopathogenesis.

Liu, Zhaoxiang; Zhang, Mingqiang; Shi, Xiaohu; Zhao, Wenhui; Cao, Chenxiang; Jin, Lixia; Wang, Yanlei; Xiao, Jianzhong

Liu, Zhaoxiang; Zhang, Mingqiang; Shi, Xiaohu; Zhao, Wenhui; Cao, Chenxiang; Jin, Lixia; Wang, Yanlei; Xiao, Jianzhong.

Afiliação

Liu Z; Department of Endocrinology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
Zhang M; Department of Respiratory and Critical Care Medicine, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
Shi X; Department of Traditional Chinese Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
Zhao W; Department of Endocrinology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
Cao C; Department of Endocrinology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
Jin L; Department of Endocrinology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
Wang Y; Department of Endocrinology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
Xiao J; Department of Endocrinology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.

Endocr Connect ; 12(9)2023 Aug 03.

Article em En | MEDLINE | ID: mdl-37410080